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                                                ABSTRACT 
 
 BACK GROUND AND OBJECTIVES :   
                                    Snake bite is a major public health problem through out 
the word especially in tropical countries like India. The objective of the study is 
to analyse the factors, which determine the prognosis of patients, admitted with 
snake bite   envenomation  . These prognostic factors include 1) Time since 
snake bite and admission to  Government  Chengalpattu  Medical college &  
Hospital, Chengalpattu 2) Whether patient received native treatments before 
admission . 3) Co morbid illness. 4) Site of bite.  
METHOD: 
                      181 adult  patients  admitted with signs of snake bite 
envenomation  were included in this study and a detail history of bite including 
time of bite, site of bite, type of snake, patients manifestation and history of 
native  treatment received before admission  was taken .A detailed history of co 
morbid illness was obtained from all patients. A detailed clinical examination 
was done and each patient was subjected to investigations like complete blood 
count, BT, CT, PT, blood urea, serum creatinine, electrolytes and ECG. All 
investigations were repeated to evaluate the progress 
 
 
 RESULTS :  
                                 Total cases studied are 181,  in which  64% are males and 
36% are females .Highest incidence of snake bite was seen in 1. Age group of  
30-40 yrs(26.8%) 2. Purely agriculture workers (46.41%) .There was more 
incidence of bite on lower extremity (50.83%). Complications are low in   
patients presenting within 6 hours of bite. Out of 181 cases of snake bite   
35.38%were neurotoxic, 25.42% were haemotoxic   and Local reactions like 
cellulitis  , edema comprises 22.65 %  and of these 9  patients expired . 
  
INTERPRETATION AND CONCLUSION           
1) A significant association was noted between prolonged bite to needle 
time and  mortality with  7  out of 9 patients(78%) who presented more 
than 6 hours after bite  were dead . 
2) There was no relation between site of bite and severity of 
envenomation 
      3)       On analysing co morbid illness versus death wise distribution of study 
population , we found that among 15 diabetic patients 93 % were alive and 7% 
were dead . Among  17 hypertensive patients only  6% died . Similarly on 
analysing all the co morbid illness with outcome we found that co morbid 
illness is not a strong determinant in determining the mortality. 
         4)     Native treatment  especially tourniquet application is a strong 
determinant of outcome with 100% prevalence in dead and 85.28%  in patients 
who had undergone  surgeries and 27.28 % in alive patients  without  surgeries .  
 
1INTRODUCTION
“The progress of the disease and succession of symptoms had either not been
attended to or, were indistinctly recollected”.
Dr.Patrick Russell (after whom Russell’s
viper has been named) wrote from India on snakebite.
In any part of the world, snake produce’s unimaginable fear
and anxiety. This fear has been present from ancient civilization. Right from
the past, snakes are the cause for one of the first poisoning heard .The death
caused then, might have been first alarm of sensing death at vision of a snake
1
At the beginning of twenty first century, annual mortality from
snakebites continues to be as high, around 30 to 60 thousand in the world.
Snakebite morbidity and mortality is a major health problem in rural areas.
Mortality rates of around 5.5 per 100,000 resident Indian rural coastal
populations tell about the magnitude of the problem. According to Frayer in
his study of Thanatophidia of India,it was estimated that about 1 in 1 lakh
population died due to snake bite
2
.But inspite of this, snake bite has been
overlooked through ages.
2Snake bite is also responsible for about 2.85%-5.3% of the
mortality of total hospital admission in India. India is reported  to have  the
highest snakebite incidence and mortality in the world
3
. World Health
Organization (WHO) estimates  the total  number of bites to be 84,000 per
year  with 11,000 deaths. A national survey in India suggests that snake bite
deaths estimated  are more than 30 fold higher than  documented. Most of the
death  are mainly  due to the snake bite  victims not reaching the hospital in
time.
The increased mortality in India is due to climatic
factors, rural predominant population and their agricultural dependence. In
addition high risk community is not well educated , about the occupational
risks of exposure  and simple precautions  like wearing slippers which can
protect against  the bite. Also many harmful practices such as cutting and
suction, tourniquets application , sucking out venom with mouth, etc are
followed in many places which all contribute to mortality and morbidity due
to snake bite.
Increased accidental exposure to snakes, due to agricultural
practices, lack of good health care services, poor access to tertiary care
services and lack of effective anti venom all contribute to the morbidity and
mortality .
3Studies signify that primary care treating doctors hesitate to treat
snakebite patients immediately mainly due to lack of experience and
confidence. At the secondary and tertiary level hospitals, several treatment
protocols and schedules  were being followed for  anti-snake venom (ASV)
administration, mainly based on foreign  textbooks. Mortality rate is further
increased by inappropriate administration of first dose of ASV particularly in
krait and Russell’s viper snakebite
5
. There is also delay in providing a simple
method of  endo tracheal intubations and  artificial ventilator  or  amboo bag
ventilation  in neuro-toxic envenoming.
In response our Health and Family Welfare Department, Government
of India, after careful analysis of trials  has prepared a National Snakebite
management Protocol for  snake bite  to provide doctors and lay people a best
evidence-based treatment approach to deal with this problem in our country
6
.
Around 235 species of snakes are found in India, most of which are
non venomous. Most of the bites , will cause  panic reaction , but  do not
cause envenomation . However, there are few snake species that are
venomous  and of these four(Big four), namely Russell’s viper (Dabiola
russelii), common cobra (Naja naja), saw-scaled viper (Echis carinatus) and
4common krait (Bungarus caeruleus) are highly venomous and believed to be
responsible for most of the poisonous bites in India
7
.
In our Government Chengalpattu Medical college &  Hospital,
situated in kanchipuram district , snake bite cases comprises a major
proportion among hospital  admissions. We are well equipped and trained in
managing this most common problem. In spite of good care and timely
management some cases end up in complications or death .
Main reasons are, patients presenting lately for treatment due to
lack of awareness , patients undergone native treatment and then getting
admitted to hospital with complications , co morbid illness of the patients. In
2012 total number of snake bite cases were 424 out of which 167 cases were
poisonous bites with signs of envenomation .
In context of the above facts this study entitled “A STUDY OF
PROFILE,MANAGEMENT AND OUTCOME OF PATIENTS ADMITTED
FOR SNAKE BITE WITH ENVENOMATION IN GOVERNMENT
CHENGALPATTU MEDICAL COLLEGE &  HOSPITAL,CHENGALPATTU
GOVERNMENT HOSPITAL’’ was undertaken to study the prevalence and
the role of different  factors in determining the outcome in snake bite
envenomation patients .
5AIMS AND OBJECTIVE
This study was carried out from June 2013 to May 2014 (one year
Study), the study was conducted prospectively . The study comprised of 181
cases of snakebite patients(>13 years )  with  signs of envenomation admitted
to the Department of General Medicine , Government Chengalpattu Medical
college &  Hospital ,Chengalpattu.
1. To know the age  and sex distribution of snake bite poisoning .
2. To study the high risk group involved and things that can be done to
prevent the incidence among them .
3. To study distribution of cases based on time, place and site of  bite .
4. To study the toxicity, complications, treatment and outcome of snake
bite envenomation in adults.
5. To study the effect of factors like Bite to Needle time, native treatment
and co morbid illness in determining the outcome.
6REVIEW OF LITERATURE
The term ‘Snake’ was derived from the Anglo-Saxon word ‘Snaca’
meaning the creeping
8
. Nearly, 240 million years ago these creeping animals
were seen and were named ‘reptiles’.
Dr.Patrick Russell
9
is the “Father of Indian Ophiology” .He gave the
earliest reference to Indian Snakes. He holds the credit for distinguishing the
venomous from the non-venomous snakes. It was he who focused attention
on the viper Vipera Russelli, which was named after him.
Sir J.B.Fayrer
10 (1873) was a physician and ophiologist .He has done
extensive research on the physiology of venom of Indian snakes. He wrote a
book in 1874, named “Thanto Ophidia of India”.
A book on the poisonous snakes of India ,by Joseph Ewarts
11 (1878)
provides valuable datas on snake bite poisoning in India.
An, ophiologist named, Col. Frank Walls
12 (1908) strived hard to gain
insight on knowledge of the habits and distribution of Indian snakes. His
work entitled “The poisonous terrestrial snakes of our British Indian
Dominions and how to recognize them “bears his stamp of authority on the
subject.
7Col. Gharpurey
13 (1935) a physician, first attempted to dispel the
superstition and ignorance woven around the Indian snakes, both venomous
and non-venomous book entitled “Snakes of India “which was  written in
semi-technical language by him, provides plenty of information  information
on the venomous snakes.
Dr.Malcolm Smith
14
(1943) ,volume on ‘’snakes in the Fauna of
British’’ Indian series continues to be a gold standard work.
Information on the clinical aspects of snake bites in India and Southeast Asia
has been given by Alistair Reid H
15(1963) .Similarly Banerjee RN and
Siddiqui ZA
16 (1974) ,Of Safdarjung Hospital, New Delhi conducted a study
of snake bites, which includes many aspects of envenomation. Sawai et al
17
of
Japan Snake Institute, published a statistical data on snakebite based on
records of the patients from different states in India ,during his visit to India
from October to December 1972.
Several medical personals  have conducted studies and
investigations  on the venoms of snakes in India and their properties . The list
of such workers is very long and exhaustive, some  pioneering work carried
out in recent times by Ahuja and Gurkripal Singh18(1954), Deoraj19 (1963-
1971) and Whitaker20 (1978), Daniel21(1983) has given details  facts and
figures in respect of the venom of the common venomous snakes.
8Murthy
22 (1985) studied about the common venomous snakes of
India and also gave valuable accounts of these snakes for the benefit for
layman. Three famous institutes in India contributed to various research on
snake  bite  namely, The Haffkine Institute  for Training, Research & Testing
in Mumbai, The Guindy Snake Park, The Snake Park in Calcutta and the
Central Research Institute, Kasauli .They served as a source for the
dissemination of knowledge ,about  venomous snakes of India and their
venom, preparation of antisnake venom sera and the treatment of snake bite,
etc.
Acoording to studies conducted by Subhadeep Sarkar, Parthsaratho
Mitra and Kunal Bhattacharya , Russel’s viper is responsible for 60 percent of
the deaths from snakebite, that occur in India every year. Death due to snake
bite is due to harmful effect of all the toxic reactions that venoms produce in
the body of the victim.
Snake venom is just a modified saliva with a combination of
many different toxic  proteins and enzymes. These constituents exert toxic
effects on entering the biological systems. Inside the snake ,venom is present
outside the circulation and physiological compartment of body, confined to
venom gland and so snakes are likely to suffer from  toxicity of venom, when
bitten by other venomous snakes. A highly potent natural antivenom
substance with greater potency and prolonged half life has been demonstrated
in rattle snake (Straight et al, 1976).
9CLASSIFICATION:
All snakes in India commonly fall basically into two families
41
.
1. Under Family colubridae, there are  three sub-families.
a) Elapidae:,These include most of the neurotoxic snakes like  Krait, Coral
snakes, Cobra and Mamba .
b) Crotalidae:it comprises  pit viper and rattle snakes.
c) Hydrophidae: Sea snakes.
2. Family Viperidae (True Vipers): These comprises many  African and
Eastern burrowing Stiletto snakes, also known as burrowing vipers  or
mole vipers .Usually attack their victims with front fang protruding
through the partially closed mouth.
The main characteristics of important poisonous snakes of India are:
a) Elapids:
This group comprises of cobra, krait and the coral. The head and
neck are of the same width and the pupils are round. The fangs are located
anteriorly but being covered by mucous membrane. Therefore these snakes
cannot bite through the dressings or inject a completely. The tails are
rounded.
10
1. Indian Cobra:
The snake measures up to 2 meters. Its colour is variable but usually
black. The head and neck are of same width, which is provided with a hood,
bearing a mark. It spreads its neck to form a hood only when frightened. The
cobra prefers populated areas and it has very vast distribution in India.
FIGURE 1: INDIAN COBRA
2. King Cobra:
This snake is larger and bigger than common cobra, it can grow up to
4.5 meters. The colour is variable from jet black to yellow, brown or black.
11
It has a hood without a mark . The tail scales are arranged proximal but with
distal division. The king cobra resides in dense jungles or forests.
FIGURE 2 : KING COBRA
3. COMMON KRAIT :
This snake grows up to 1.50 meters. It is usually glistening black colour
and has white arches across the back beginning from the head. It has a row of
hexagonal central scales on the back with a creamy white belly. Large shields
cover the head with complete tail scales. Usually prefers to reside near the
house and is responsible for a large number of cases of poisonous  snake bite
in India.
12
FIGURE 3: COMMON KRAIT
4. Banded Krait :
This snake is much bigger than the common krait and grows up to 2
meters. In addition to the features of the common krait, as the name implies it
has alternate yellow and black bands in its back. It is commonly found in
Assam, Bengal and many regions of south India.
13
FIGURE 4 : BANDED KRAIT
Vipers:
This group is classified as pit vipers and pit less vipers. The pit
which is situated between the nostril and the eyes help them  to detect prey in
the dark. The shape of head is triangular much wider than the neck and the
pupils are vertical.  They have a long fang that is movable and canalized like
a needle. Thus this snake can bite through dress and gives a full dose.
The fangs are clearly visible when erected but it is tucked by the
side of the upper jaw. The bites of pit vipers are not fatal while those of pit
less vipers are harmful to man. The tail is tapering. The bamboo snakes are
pit vipers while the Russell’s viper and saw-scaled viper are pit less vipers.
14
1. Russell’s Viper :
This snake grows up to about 1.5 meters; it is brown in colour and has
three rows of black spots or chains on the back. It is stouter than all other
poisonous snake, it can be identified by:
a) A flat head with a distinct ‘V’ mark with its forward pointing apex .
b) Small head scales
c) Broad belly plates and
d) A short tail with covering shields . It has bigger nostrils  than other  snakes.
It makes a distinct hissing sound, at time of bite. It is widely found in
dense jungles.
FIGURE 5 : RUSSELL’S VIPER
15
2. Saw Scaled Viper (Echis Carinata, Phoorsa, Echis or Afai) (Figure-9):
This snake grows up to 70 centimetres. Its is brown or brownish
grey in colour. It shows following features.
a) Head resembles a triangular arrow with a white mark an arrow.
b) A diamond shaped area on each flank between the curves of wavy lines.
c) Small scales in head.
d) Broad belly plates
e) Undivided shields in tail  and
f) Body scales appear like a saw and hence it is  named so . It  makes a
distinct  rustling sound while moving . This snake is found throughout
India.
FIGURE 6 : SAW SCALED VIPER
16
POISONOUS VS NON POISONOUS SNAKES:
Because the most of poisonous snakes are members of the
pit viper family, we can easily  differentiate between poisonous and
harmless snakes. The three ways to distinguish poisonous snakes:
Pupil Shape: Pupils of harmless snakes are round. Poisonous snakes
have cat-like (elliptical) pupils. In good light, we can easily see the pupil
shape from a safe distance because snakes cannot jump nor can they strike
from more than one-third of their body length.
Pit: Poisonous snakes also have a very conspicuous sensory area or pit
(hence the name "pit viper") on each side of the head. The pit looks somewhat
like a nostril and helps the snake locate warm-bodied food. It is located about
midway and slightly below the eye and nostril. Harmless snakes do not have
pits.
FIGURE 7: VIPER WITH PIT
17
SCALE ARRANGEMENT:
The underside scales of a venomous snakes tail go all the way across
in a single row from the anal plate. The very tip of the tail may have two scale
rows. Non-poisonous snakes have two rows of scales from the vent to the end
of the tail. This characteristic can also be observed on skins that have been
shed.
FIGURE 8: POISONOUS VS NON POISONOUS  FANGS
18
Other features that help to identify a poisonous snake at a distance:
Head Shape: All Venomous snakes usually have a triangular (wide
at the back and attached to a narrow neck) or "spade-shaped" head.
Sometimes many harmless snakes can also flatten their heads when
threatened and may appear poisonous.
Distinctive Sound:
Rattlesnakes  usually produce a warning rattle (a buzz or a dry,
whirring sound) when approached. However, many non-poisonous snakes
(black racers, rat snakes, milk snakes, and pine snakes) and several poisonous
snakes (copperhead and cottonmouth) often vibrate their tails when
threatened. The sound produced by this vibration often imitates a rattle or
hissing sound when the snake is sitting in dry grass or leaves.
FIGURE 9  : RATTLESNAKE RATTLES
19
TAIL: It can be easily recognized by young cottonmouths and copperheads
by their bright yellow or greenish yellow tail.
FIGURE 10 : POISONOUS AND NON POISONOUS SNAKE
DIFFERENCE
20
Site of bite and bite marks :
Most of snake bites are common during evening and night time . most
common site of bite is lower limb . But other sites like hand , head and neck
may also be involved . Many research works  have been done in past to find
the relation between site of bite and toxicity .
FIGURE 11 : SNAKE BITE IN FOOT
21
FIGURE 12 : SNAKE BITE WITH CELLULITIS IN HAND
Venom Composition
23,24
:
Snake venom is a mixture of several chemical compounds. Charles Lucien
Bonaparte , brother of Napoleon Bonaparte, was the first to describe the
proteinaceous nature of snake venom in 1843.
Proteins constitute 90-95% of venom  and they are responsible for almost all
of its biological effects. Most of these are enzymes which are mentioned
below
1. Neurotoxins
2. Fibrinolysins
22
3. Cholinesterase
4. Proteolysins
5. Hemolysins
6. Agglutinins
7. Cardiotoxins
8. Coagulase, hyaluronidase, lecithinase, etc.
Inflammatory mediators such as histamine and 5 hydroxytryptamine may be
partly responsible for the pain at region of snake bite
Neurotoxins (Polypeptide Toxins):
These are low molecular weight proteins found in elapids, vipers and
hydrophids. They  chiefly act at the peripheral neuromuscular junction ,either
acting pre or post-synaptically. They either block the release of acetylcholine
from the pre synaptic terminal or its interaction with its receptors, thereby
preventing conduction of impulses  to muscles especially those associated
with breathing and extra ocular muscles. Post synaptic neurotoxins in cobra
venom, such as cobratoxin and α-bungarotoxin  bind to acetylcholine
receptors on the motor endplate. Presynaptic neurotoxins in krait ,such as β-
bungarotoxins, crotoxins are phospholipases A
2
which prevents the release of
acetylcholine at  neuromuscular junction by blocking voltage gated potassium
channels.
23
Haemolysins:
Snake venom affects almost all components of hemostasis like
vascular wall,platelet,coagulation,fibrinolysis
24
.Haemolysins are responsible
for haemorrhagic activity in viperidae venoms and it causes haemorrhage by
damaging vascular endothelium and by inhibiting platelet aggregation.
Procoagulant enzymes mainly acts at various points of the clotting cascade
while fibrinolytic factors may act directly or by activating plasminogen.
Fibrinolysis and associated platelet abnormalities causes  persistent bleeding
from vessels.
Myotoxins;
Produce muscle necrosis and myoglobinuria.the ongoing
inflammation will cause edema and some time causes rhabdomyolysis.
Proteolytic Enzymes: causes  breakdown of tissue proteins, damage cells and
tissues at the site of bite causing local pain and swelling. Thus they also
favour penetration of toxins to deeper tissues.
Hyaluronidase: Facilitates penetrations of  venom into the tissue and its
rapid absorption. It produces edema,localised  swelling and absorption of the
toxin at the site of bite. Other enzymes include collagenases,
24
phosphoesterases, monoesterases, acetyl cholinesterase, ribonucleases,
deoxyribonucleases, lactate dehydrogenases. The role of these enzymes in
human envenoming is uncertain.
SYMPTOMATOLOGY:
The symptoms and signs in a patient with snake bite envenomation  are
dependent upon a number of factors.
1. Age and General Health of the Victim:
Children and elderly persons  are more likely to succumb
easily because of poor general health condition .Younger patients are also
at a greater risk because of higher concentration of snake venom in
relation to the body volume .Old persons with features of dementia and
visual disturbances are at high risk.
2. Amount of Venom Injected:
A bite by a poisonous snake may not be always poisonous.This
depends on factors such as  condition of the fangs and venom apparatus , such
as when snake bites a man after having a recent kill of prey it will be able to
inject only small quantity of venom or no venom at all. This is the reason why
only some persons develop signs of envenomation  after a poisonous snake
bite.
25
Other factors like the kind of clothing at time of bite through which
the fangs pass, factors tha make the snake to bite and the length of time the
snake holds on will determine the amount of venom injected.
3.Nature, Location, Depth and Number of Bites:
More deeper and more the number of bites, more likely it will be
lethal ,due to the direct injection of venom into a blood vessel .It will lead to
rapid dissemination of venom in to circulation and severe systemic
envenomation. Bite through clothing is less dangerous than bite on a bare
limb. Some studies have shown that bite in upper limb and face is more likely
to be lethal than in other sites
4. Type of Snake Involved:
This will decide the symptomatology. If the snake is identified as
poisonous or non-poisonous and amongst the former as Elapidae
(neurotoxic)or Viperidae(hemotoxic) much of the clinical signs and
symptoms can be predicted and managed accordingly. Bite by a venomous
snake needs urgent management instead of mere observation  in case of
non venomous or unknown snake bite
5. Individuals Sensitivity to Venom:
It will vary from person to person. Based on this various studies
have been conducted regarding desensitization as a form of protection against
snakebite. Anaphylactic shock can occur in a person repeatedly bitten by
snakes.
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6. Economic status :
Relationship of poverty and snakebite incidence and mortality has
been clearly demonstrated
26
. The Day to day survival of many of the rural
poor, in India and other developing regions of the world, like Africa are
based on low cost, non mechanized farming , which puts them at risk of
bite.
7. First aid treatment and Subsequent Medical Care:
This is the important  factor, which is under our control . Proper
first aid management and timely intervention will naturally decide the
prognosis. Even in case of venomous snakebites, over half of the victims
escape without serious poisoning. Snake venom poisoning may vary from
trivial symptoms  to extremely grave outcomes . So timely administration
of ASV and early referral to tertiary centres improve the outcome.
8. Pathogens Present in the Snakes Mouth:
Apart from toxic effects of snake venom,  gram negative and
anaerobic organisms are infiltrated at the region of bite . If infection develops,
clinical clue to anaerobic infection will be presence of a foul odour. This will
add to morbidity especially in diabetic patients.
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9. Absorption of the Venom:
Systemic absorption of the venom is mainly via the lymphatic route,
although venous absorption can also occur with low molecular weight venom
such as cobra venom. Bite over a blood vessel causes very rapid
envenomation and systemic manifestations  and the mortality is very high
25
.
10. Native treatment :
Many people in rural areas go for native treatment for snake bite
.Many scientifically disproved treatments like tourniquett application ,
cutting, puncturing etc, carries more harm . Many studies have shown the
possibility of surgical complications and amputations in those cases
.Mortality also high in such patients.
FIGURE 13: TOURNIQUETT APPLICATION
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Seasonal Incidence:
There is a definite seasonal pattern in cases of snakebites
poisoning. Most of the cases were reported in the 3
rd
quarter of year i.e., July
to September. This is due to the fact that this is the monsoon season and
rainfall forces snakes to venture out of their water-filled pits and there is
increased human activity in fields in at this period as it is the sowing season.
A similar trend was observed by Viramani SK and Dutt OP
64
.
CLINICAL FEATURES OF SNAKE BITE:
The symptoms and signs of envenomation depends on the nature of
the venom, the dose and the site of injection26. The clinical features of snake
bite can be divided into local and systemic.
1. Local Manifestation:
Pain: Local pain and swelling are the commonest symptoms, it
usually starts within minutes of the bite. During the next few hours pain
intensifies and spreads towards the trunk and  becomes localized in the lymph
nodes draining the bite site. Symptoms are more rapid with cobra bite. Some
29
patient complains of vague abdominal pain (especially in krait bite) within 6
hours of bite.
Swelling: Swelling usually develops at the site of bite within minutes
up to 48-72 hours. It will become greatest at 1 to 4 days. Both local pain and
swelling is more in viper bite
27
. This is followed by oedema, and appearance
of bullae, which can progress rapidly to involve the trunk
28
.
Neurological symptoms:
Acute neuro muscular weakness with respiratory failure is
most important manifestation. Most of the patients with neuro toxic bites
develop ptosis and opthalmoplegia .Sensory disturbance like Tingling and
Numbness over the tongue, mouth, scalp and around the wound occur mostly
in viper bites.
Weakness of the muscles increases and develops into paralysis of the lower
limbs. The paralysis then spreads to the trunk and affects the head, which
droops. After half to one hour, there is excessive salivation and even
vomiting. Single breath count is performed to identify the patients in
impending respiratory failure and plan for intubation.
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FIGURE 14 : PTOSIS IN AN YOUNG MAN WITH NEUROTOXIC
SNAKE BITE
Haematological features:
Petechial and/or purpuric rash is seen most commonly with
viperidae family
29
. The local area of bite may become devascularized with
features of ischemia and  necrosis predisposing to  gangrene. Generally elapid
bites result in early gangrene, usually wet type, whereas vipers cause dry
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gangrene of slower onset (over weeks). It is caused mainly by direct cytotoxic
venom effect. Massive haemorrhage which warrants transfusion are also
common.Intra cerebral haemorrhage is a dreaded complication.
There are two case reports of Raynauds phenomenon and gangrene
in a limb bitten by Russell’s Viper
30
, secondary infection including tetanus
and gas gangrene may also result
31
.
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FIGURE 15: IDENTIFICATION OF BITE BASED ON SIGNS
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Systemic Manifestations:
The most common and earliest symptom following snake bite is
fright and anxiety, because of  fear of dying .Many patients present symptoms
which are direct result of fright irrespective of either poisonous or non
poisonous bite. Patient may complain of sudden onset of weakness, defective
vision ,difficulty in breathing ,dysphagia, syncopal attack, etc.
These symptoms have to be differentiated from that of
neurotoxicity
32
. The time of onset of poisoning varies in different species,
cobra produces symptoms as early as 6 to10 minutes, after bite, viper takes 7
to 15 minutes however symptoms may be delayed for several hours. Sea
snake bites almost always produces myotoxic features within 3hours
33
.
Elapid venoms produce  paralytic effect but cobra bite
commonly causes, severe local pain, swelling, blistering and tissue necrosis.
Paralysis may be delayed for 7 – 12 hours after bite. These victims often
presents with preparalytic symptoms like vomiting , blurred vision,
drowsiness and tingling sensation around the mouth, paralysis first appears as
bilateral ptosis and external ophthalmoplegia and then spreads to involve
muscles of palate tongue, jaw, neck, larynx, and finally respiration. Finally
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leading to generalized flaccid paralysis, consciousness is maintained through
out, provided there is no cardiac or respiratory failure.
In general the viperidae venoms are best known for their
severe local manifestations, haematotoxic effects  and  renal failure  In none
of the studies done in other countries was the presence of neurological
manifestations recorded
36
.
Some times Russells vipers systemic envenomation may
develop in the absence of local reactions. . Russells viper venom activate
factors V and X and cause fibrinolysis. Certain venoms cause
defibrinogenation by activating endogenous fibrinolytic
system
37,38.
.Spontaneous systemic bleeding resulting from haemorrhagins,
which damage vascular endothelium and some times the blood does not
coagulate due to consumption coagulopathy.
All these effects result in bleeding from gum,
epistaxis, haematuria,  haematemesis and malena, kidney, from fang marks
and even from vene puncture sites and some times as multiple petechiae and
purpurae
39,40
. Intra cerebral haemorrhage (Subarcahnoid haemorrhages and
cerebral haemorrhage) have also been reported40.
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Hypotension and shock mainly result from hypovolaemia due to
massive haemorrhage or extravasation of fluid from the intra vascular
compartment into the swollen limb. Vasodilation and a direct action on the
myocardium is mainly seen in viper bite
41,42
.
Almost every species of snakes can cause renal failure. It is fairly
common following Russell’s viper bite and is also a major cause of death
42
.
Mechanism of renal damage include ischaemia (from hypotension, renal
vasoconstriction or disseminated intravascular coagulation), haemorrhage,
direct nephrotoxicity ,acute tubular necrosis , pigment nephropathy associated
with massive intravascular haemolysis, generalized rhabdomyolysis and
associated electrolyte disturbances
41
.
Acute interstitial nephritis due to snake venom have also been
observed
43
, Cardiotoxic features, include tachycardia, hypotension or
hypertension and ECG changes including sinus tachycardia, ischaemic non-
specific ST-T changes, arrhythmias and artrio-ventricular blocks. This
cardiotoxicity is seen in 25% of viperine bites
44
.
Myalgic features are the most common presentation of bites by
sea snakes. Muscle necrosis may also result in myoglobinuria. Rare systemic
36
manifestations including hypopituitarism
45
, bilateral thalamic haematoma
46
have also been reported
Severity assessment.
Snakebite severity score (SSS) was given by Dart et al.,1996 and
Nualnong et al., 2005
47,48
. The grading of severity was based on severity of
symptoms or signs observed. The severity was graded from 0 to 4 ,ranging
from no envenomation to severe life threatening symptoms and death taking
into consideration clinical signs/symptoms and/or laboratory data.
The four levels represent as follows; grade 0 for no symptoms
or signs, grade 1 for mild, transient and spontaneously resolving symptoms or
signs, grade 2 for moderate, pronounced or prolonged symptoms or signs,
grade 3 for severe or life threatening symptoms or signs, while grade 4
represents extremely severe envenomation leading to mortality. Occurrence
of a particular symptom was checked against the chart  and graded.
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TREATMENT OF SNAKE BITE:
First Aid Management
49
The majority of current first aid methods adopted by victims such as
tourniquets, cutting ,biting and  suction ,herbal remedies,application of heat
are completely ineffective and dangerous. Current recommendation is  to
adopt what has been called the ‘Do it R.I.G.H.T.’ approach, stressing the need
for Reassurance, Immobilisation as per a fractured limb, Getting to Hospital
without delay and Telling the doctor of any symptoms that develop.
Support Posters and pamplets have been designed detailing this
method and providing pictures of the major venomous species. It is
recommended that these posters are given the widest possible distribution
throughout the State in schools, community centres, hospitals and other
public places.
1. Reassurance: The patient should be reassured by pointing out that all
snakes are not poisonous, even poisonous snakes cannot always inject a
lethal dose.
2. Immobilize the bitten limb with a splint. Avoid applying tourniquets or
pressure bandages
3. Getting to Hospital without delay
4. Telling the doctor of any symptoms that develop.
Hospital Treatment:
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Indication for Antivenom Treatment:
A) Systemic Envenoming:
1. Neurotoxicity (Ptosis, ophthalmoplegia ,diplopia etc.).
2. Incoagulable blood indicating consumption coagulopathy (DIC).
3. Spontaneous systemic bleeding like bleed from  bite site ,gingival bleed
,epistaxis,hematuria,etc
4. Hypotension (shock).
5. Generalized rhabdomyolysis .
6. Impaired consciousness.
B) Severe, Local Envenoming:
1. Extensive local swelling (involving more than half of the bottom limb).
2. Rapidly evolving local swelling (extending beyond the bitten segment
of limb, for example above the ankle in bite on the foot) within one
hour of bite.
3. Bites on the digits (fingers and toes) where venom is known to cause
local necrosis (e.g., viper and cobra).
Monospecific (monovalent) antivenom is ideal if the biting
species is known, polyspecific (polyvalent) antivenom in India is effective
against the four common varieties of snakes. It is prepared from the horse’s
serum hyper-immunized with the venom. It is seen that in large number of
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envenomations the  type of snake could not be identified. So in Indian
situation, it is probably safer for the time being to use the polyvalent anti-
snake venom (ASV).
The optimal therapy of poisonous snake bite remain controversial.
The optimal dose of ASV, frequency of administration and duration of
therapy remains unclear. There are no clearly defined end points for stopping
ASV therapy in neurotoxic cases
50
. While treating viper bite cases one should
not hesitate to use higher dose of ASV, if the coagulation parameter remains
abnormal. Dose of ASV should be repeated (preferably every 6 hours) until
coagulation time returns to normal.
Coagulation parameters should be repeated several times
because value may be transiently normal and later on may become abnormal.
This is probably due to continued release of venom from injection site and
this warrants repeating ASV, as half life of ASV is 26 to 95 hours and initial
lethal dose of ASV may not prevent late envenoming.
Swelling at the site of bite may be used as a possible
indicator to give further dose of ASV, when there is a doubtful picture of
coagulation abnormality
52,53
. Each one of polyvalent ASV neutralizes not less
than the following quantities of standard venoms tested in mice by
intravenous route.
• Cobra (Naja Naja) - 0.6 mg.
• Common krait (Bungarus Caerueus) - 0.45 mg
40
• Russells viper (Vipera Russelli) - 0.6 mg
• Saw scaled viper (Echis carinatus) - 0.45 mg
Dosage
53
:
The current medical education in India is reliant on Western
textbooks for snake bite management. This has led to inapplicable protocols
being employed in particular the inappropriate administration of polyvalent
anti snake venom (ASV) when it is not required and/or in doses well in
excess of the required amount. The current protocol has been developed in the
Indian context and with reference to Indian species.
Research has shown that PHCs do not treat snakebite mainly due to
confidence issues and the ability of Primary Health Centres to deal
with snakebite should be increased. The earlier an envenomed patient is
treated with ASV, better the outcome.
ASV Administration Criteria
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The grounds for administering ASV have been rationalised to better suit the
Indian context. It should be administered if there is significant envenomation
i.e. incoagulable blood shown by the 20 WBCT or significant limb swelling
for viperine bite, neurological signs for elapidae bite.
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FIGURE 16 : 20 MINUTES WHOLE BLOOD CLOTTING TIME
ASV Dosage & Repeat Dosage
The recommended initial dose of ASV is 8-10 vials administered over
1 hour. Mode of administration is IV only
 Repeat doses for haemotoxic species is based on the 6 hour rule
 Repeat doses for neurotoxic is based on the 1-2 hour rule.
 The maximum recommended dose for haemotoxic bites in 30 vials of
ASV
 The maximum recommended dose for neurotoxic bites is 20 vials of
ASV
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Neurotoxic Bite Support Measures
Despite the fact that the neostigmine test was actually an Indian discovery, it
is still poorly used in India. The neostigmine test should be carried out in all
neurotoxic bites But should be accompanied by objective measures of
improvement. It is an all or nothing test. If there is no positive response to
first dose, the neostigmine should be discontinued.
The Management of Snakebite in Primary and Community Care
Hospitals
All PHC/CHCs are capable of managing the initial stages of snakebite
if confident and equipped and with explicit referral criteria. Where the new
protocol has been trialled this is becoming more evident.
A basic drug and equipment profile for the PHC/CHC has been proposed.
This includes methods for calculating the ASV requirement. It should be
noted that many States already have ASV in PHC/CHCs but doctor
confidence is preventing usage.
Haemotoxic bites with correct signs of envenomation can be treated
with 8-10 vials of ASV,  if any ASV reaction occurs treat with adrenaline and
then transferred to a higher centre with the ability to carry out the required
blood tests to identify occult bleeding or renal impairment.
Neurotoxic bites with correct signs of envenomation can be treated
with 8-10 vials of ASV, stabilised if any ASV reaction occurs with adrenaline
and administered the neostigmine test. If there is no evidence of impending
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respiratory failure, determined by patient ability to perform a neck lift the
patient can be treated locally. If the patient is unable to perform a neck lift
then they will be transferred to a higher centre with mechanical ventilatory
capability. Transfer steps including airway support are specified.Support
Posters have been prepared in support of the Protocol for use at the bedside in
PHC/.CHCs, District Hospitals and Tertiary centres
It is not advisable to inject venom antiserum at the local site of skin
bite.
ASV REACTIONS:
Antivenom can cause two types of reaction, an early
(anaphylactoid reaction) and a late (serum sickness type) reaction. The early
(anaphylactoid) reaction is characterized by itching, urticaria, cough, nausea,
vomiting, fever and tachycardia. Some may develop systemic anaphylaxis
with hypotension, bronchospasm and angioneurotic oedema. This is treated
with adrenaline 0.5 to 1.0 ml subcutaneously (may be repeated),
chlorpheniramine maleate 10 mg IV and hydrocortisone 100 mg IV
54,55
MANAGEMENT OF SHOCK:
If the patient is hypovolaemic, indicated by supine or postural
hypotension, empty neck veins, sunken eyeballs, loss of skin turgor and
dryness of mucosae, proceed as follows:
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1) Establish intravenous access
2) Bladder catheterisation
3) Central venous pressure monitoring :
This can be achieved either by observing the vertical height
of the jugular venous pulsation above the sternal angle with the patient
propped up on pillows at 45
o
; or by direct measurement of central
venous(superior vena caval) pressure through a long catheter preferably
inserted at the antecubital fossa.
The catheter is connected to a saline manometer, the 0
point of which must be placed at the same level as the right atrium (that
is, at the sternal angle when the patient is propped up at 45
o). In
someone who is obviously volume-depleted, resuscitation should start
immediately, and not be delayed until a central venous line has been
inserted.
4) Fluid challenge:
Depending on the initial state of hydration/dehydration, an
adult patient can be given two litres of isotonic saline over one hour or,
until the jugular venous pressure/central venous pressure has risen to 8-
10 cm above the sternal angle (with the patient propped up at 45o). The
patient must be closely observed while this is being done. The fluid
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challenge must be stopped immediately if pulmonary oedema develops.
If the urine output does not improve, try furosamide challenge.
5) Furosamide challenge:
60-100 mg of furosamide is injected slowly (4-5
mg/minute). If this does not induce a urine output of 40 ml/hour, give a
second dose of furosamide, 200 mg. If urine output does not improve,
try mannitol challenge.
6) Mannitol challenge:
175 ml of 20% mannitol may be infused intravenously
over 15 minutes but this must not be repeated ,as there is a danger of
inducing dangerous fluid and electrolyte imbalance. An improvement
in urine output to more than 40 ml/hr or more than 1 litre/day is
considered satisfactory.
7) Conservative management:
If the patient is still oliguric, despite these challenges,
diuretics should be  stopped and fluid intake should be restricted to a
total of the urine output plus "insensible losses" (500-800 ml/day). If
possible, the patient should be referred to a nephrology unit. The diet
should be bland, high in calories (1800/day), low in protein (less than
40g/day), low in potassium (avoid citrus fruit, fruit juices and
potassium-containing drugs) and low in salt. Infections will lead to
tissue breakdown and increase urea levels. So infections should be
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prevented or treated promptly with non-nephrotoxic antibiotics (ie
avoid aminoglycosides such as gentamicin).
8) Biochemical monitoring:
Serum potassium, urea, creatinine and, if possible, pH,
bicarbonate, calcium and phosphate should be monitored frequently. If
this is not possible the electrocardiogram (ECG) should be examined
for evidence of hyperkalaemia, especially following bites by sea
snakes, or Sri Lankan or South Indian Russell’s vipers or if the patient
is passing dark brown urine, indicating rhabdomyolysis or intravascular
haemolysis
Compartment syndrome and fasciotomy
The presence of an immobile, swollen,shiny, cold and
apparently pulseless snake-bitten limb may suggest the possibility of
increased intracompartmental pressure, especially if the digital pulp spaces or
the anterior tibial compartment are involved. Swelling of  affected muscle
within tight fascial compartments will result in an increase in tissue pressure
above the venous pressure, resulting in ischaemia. However, the classical
signs of an intra compartmental pressure syndrome may be difficult to assess
in snakebite victims.
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Clinical features of compartment syndrome
1) Disproportionately severe pain
2) Weakness of intracompartmental muscles
3) Pain on passive stretching of intracompartmental muscles
4) Hypoaesthesia of areas of skin supplied by nerves running through
the compartment
5) Obvious tenseness of the compartment on palpation
Criteria for fasciotomy in snake-bitten limbs
1) Haemostatic abnormalities have been corrected (antivenom with or
without clotting factors)
2) Clinical evidence of an intracompartmental syndrome
3) Intracompartmental pressure >40 mmHg (in adults)
Rehabilitation :
Restoration of normal function in the affected part after
the patient has been discharged from hospital is not usually supervised.
Routine physiotherapy may help to accelerate this process. In patients
with severe local envenomation , the limb should be maintained in a
elevated position. In order to prevent the deformity leg should be kept
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in functional position .For example, in the leg, deformity of the ankle
can be prevented by application of a back slab.
FIGURE 17:FASCIOTOMY DONE IN A PATIENT WITH COMPARTMENTAL
SYNDROME
Other Measures:
1. Respiratory paralysis should be treated by artificial ventilation.
2. Hypotension and shock should be treated with fresh whole blood or
fresh frozen plasma, dopamine and hydrocortisone.
3. Oliguria and renal failure should be treated conservatively failing
which dialysis should be done.
4. Local infection should be prevented by antibiotics covering gram
negative organisms and anaerobes. All patients should receive
antitetanus prophylaxis.
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5. At a later stage some patients may require surgical debridement, skin
grafting or fasciotomy.
6. Haemostatic disturbance should be treated with fresh whole blood or
fresh frozen plasma or platelet concentrates.
Do Not’s in Snake Bite:
• Local incision and suction of wound.
• Application of ice packs and potassium permanganate.
• Application of tight constriction bands impeding arterial flow.
• Infiltration of antivenom locally.
COMPLICATIONS OF SNAKE BITE:
1. Respiratory Failure: In cases of severe poisoning by Elapid snakes there
can be paralysis of the intercostal muscles and diaphragm leading to
respiratory failure. Patients may have confused, drowsy, stuporous or even
comatose. The respiratory failure is of type-II i.e., there is both arterial
hypoxia as well as hypercapnia.
2. Shock: One of the most important complications of envenomation is shock
due to large amount of peptide and protein content of the venom. Patients
may show signs of peripheral circulatory failure with or without signs of
impending coma, hypotension, renal failure, dehydration and electrolyte
disturbances
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3. Renal Failure: This is particularly seen in case of severe envenomation
following bites by vipera Russelli. The cause of renal failure is due to
ischaemia ,haemorrhage into the kidney, resulting from hypotension,
disseminated intravascular coagulation and renal vasoconstriction. The
renal cortical necrosis is due to the schwartzman like phenomenon
56
,
patients may have a decreased urine output of less than 400 ml/ 24 hours
associated with fluid and electrolyte imbalance.
4. Gangrene:
Neglected local necrosis can result in gangrene of the limb. So
the wound should be examined frequently for evidence of necrosis. Early
signs of necrosis include blistering, blackening of the skin, loss of
sensation and a characteristic smell of putrefaction. There is high risk of
secondary infection and so the necrotic tissue  should be debrided under
local or general anesthesia as soon as possible.
Haematological alterations following viperidae snake venom poisoning:
 Haemoglobin: In systemic viper poisoning, anaemia caused by loss of
red cells into the bitten limb and haemorrhage may result in a fall in
haemoglobin of over 8 gm/ 100 ml
57
.
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 Bleeding and clotting time: In most cases of  envenomation, bleeding
and clotting times will be prolonged. A 20 minutes whole blood
clotting test  is a simple and extremely sensitive bedside test of
systemic envenoming. With venom producing non-clotting blood , this
always precedes abnormal bleeding, thus there can be non-clotting
blood without abnormal bleeding but the reverse, abnormal bleeding
with normal clotting is not observed.
 Platelet count: Platelet count may fall during the first few days after
the bite, later it will return to normal level. Hess’s test is usually
positive.
 Plasma fibrinogen: Plasma fibrinogen is reduced in amount. There is
continuous microcoagulation of fibrinogen with virtually simultaneous
disposal of resulting fibrin.
 Fibrin degradation product: It’s concentration is increased  in blood
and urine
 Factors V and VIII:
The levels are reduced.
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 Coagulation profile: prothrombin time and activated partial
thromboplastin time are  usually prolonged.
 Prothrombin  time: It is usually prolonged.
PREVENTION:
Following tips will help one to escape snake bite
58
:
1. Avoid putting your limbs  in places where your vision can’t reach.
2. Do not handle snakes which are just killed and dying.
3. Avoid work at night in an endemic area without footwear. Farmers
and agriculture based workers  are motivated to use low cost foot
wears.
4. The area and the surroundings of any human habitation or working
fields should be kept clear of all ,bushes, herbs, garbage and rubbish to
prevent sheltering of snakes.
5. Food should be kept away from sleeping place. It attracts rodents
which in turn attract snakes.
6. Clean the floor under good light source before going to bed ,
especially in homes with mud floors
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7. If a snake is encountered, it is safer to keep perfectly still. The
snakes movement then could be judged and it can be distracted by
throwing down some object.
Other measures to reduce incidence of mortality and morbidity:
1. Always take the patient immediately to the doctor rather than
restoring to mantras or any other traditional treatment by non-medical
persons. Public health education is the most important to emphasize about
this.
2. All primary health centres should be fully equipped with facilities
to give first aid measures and administer specific antisnake venom if
required.
3. As snake bite is primarily a rural occupational hazards, educating
the people regarding readily available effective treatment may drastically
bring down the morbidity and mortality associated with treatment by
quacks.
If the precautions mentioned above are observed then the incidence of
snakebite and its morbidity and mortality can be reduced considerably
59
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METHODOLOGY
This study was carried out from June 2013 to May 2014(one
Year Study), the study was conducted prospectively . The study comprised of
178 cases of snakebite poisoning admitted to the Department of General
medicine , Chengalpattu Government Hospital.
Objectives of the Study:
1. To know the incidence of snake bite poisoning, time and site of bite
and  incidence among various sex and age groups and seasonal
variation among  patients admitted with snake bite poisoning  in
department of General Medicine.
2. To study the clinical presentation, complications, treatment and
outcome of snake bite envenomation in adults.
3. To study the risk factors associated with complications.
4. To suggest measures to prevent deaths from snakebite poisoning.
The patients were studied, from the time of admission and followed up
till discharge from the hospital or till death.
The data was collected from:
1. Preformed systematic questionnaire
2. Information gathered from treating Doctors in respective
Medical units
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3. Information from the victims or the relatives present regarding
socioeconomic status, family history, time of bite, type of snake,
and first aid measures taken.
The statistical analysis of the data collection was done and presented as
results and observations in tabular form and graphs and charts.
Inclusion criteria:
1. All patients with signs and symptoms of  snake bite envenomation  of
either sex of  age >13 years admitted to Medicine Department .
At the time of admission enquiry is made about the type of
snake, time of snakebite, site of snakebite, the signs and symptoms, and any
first aid measures taken. Inquiry was also made about the preliminary data of
the victim, such as age and occupation. In most of the cases, the history is
elicited by the patient himself but in certain cases by the close relatives or by
the accompanying people.
General Physical Examination:
The vital signs like pulse rate, blood pressure, respiratory rate and
level of consciousness were noted. The site of the snakebite was examined for
any local tissue reaction, such as swelling, erytherma, necrosis.
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An attempt was made to correlate the pattern of fang marks with the type of
alleged snake
Systemic Examinations:
A detailed examination of central nervous system, cardiovascular system,
respiratory rate and per abdomen was carried out in all the cases.
Laboratory Investigations:
The blood was sent for the routine haematological investigations with a detail
study of coagulation profile.
The treatment was instituted as early as possible:
1. Immediate resuscitative measures
2. Administration of anti-snake venom.
3. Symptomatic treatment
Exclusion Criteria:
1. Patients admitted for snake bite but without signs of envenomation .
2. Patients admitted with history of unknown bites or other bites without
signs of snake bite envenomation
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P<0.05
RESULTS
Table No. 1:- AGE Vs SEX WISE DISTRIBUTION OF STUDY POPULATION
AGE (years)
MALE FEMALE TOTAL
Number Percent Number Percent Number Percent
13 -19 7 6.03 1 1.54 8 4.42
20-24 10 8.62 3 4.62 13 7.18
25-29 12 10.34 2 3.08 14 7.73
30-34 19 16.38 8 12.31 27 14.92
35-39 8 6.90 14 21.54 22 12.15
40-44 11 9.48 14 21.54 25 13.81
45-59 15 12.93 11 16.92 26 14.36
50-54 12 10.34 5 7.69 17 9.39
55-59 11 9.48 4 6.15 15 8.29
60-64 7 6.03 2 3.08 9 4.97
>65 4 3.45 1 1.54 5 2.76
TOTAL 116 100 65 100 181 100
χ² 0.000101
As per table 18.307
Degree of freedom 10
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Figure  No.18:- AGE Vs SEX WISE DISTRIBUTION OF STUDY POPULATION
Among 181 cases, maximum number is 27 (14.92%) belong to 30-34 years of
age Around 26.8%of cases belongs to fourth decade. Least number of cases
5(2.76%) belongs to >65 years of age. In the study of population males were
64.1% and females were 35.91% An significant association was found
between age and sex study of population.
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TABLE 2:- OCCUPATION WISE DISTRIBUTION OF STUDY POPULATION
OCCUPATION
MALE FEMALE TOTAL
Number Percent Number Percent Number Percent
AGRICULTURE 72 62.07 12 18.46 84 46.41
INDUSTRY 1 0.86 4 6.15 5 2.76
STATE GOVT., 7 6.03 1 1.54 8 4.42
CENTRAL GOVT 0 0.00 1 1.54 1 0.55
BUSINESS 3 2.59 4 6.15 7 3.87
SMALL TRADE 5 4.31 3 4.62 8 4.42
PRIVATE 3 2.59 4 6.15 7 3.87
NOT WORKING /HOME
MAKE 13 11.21 35 53.85 48 26.52
FOREST WORKER 2 1.72 0 0.00 2 1.10
STUDENT 9 7.76 1 1.54 10 5.52
SNAKE HANDLER 1 0.86 0 0.00 1 0.55
TOTAL 116 100 65 100 181 100
P<0.05
So, the hypothesis is accepted
60
FIGURE 19 : OCCUPATION WISE DISTRIBUTION OF STUDY POPULATION
Out of 181 cases of snake bite , majority of cases i,e 46.41% are agriculture
labourers .One case is a snake handler . Around 48 cases (26.52%) are not
working or home make.
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Figure 2:- OCCUPATION WISE DISTRIBUTION OF STUDY POPULATION
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TABLE NO. 3:- IDENTIFIED SNAKE Vs UNIDENTIFIED
SNAKE WISE DISTRIBUTION OF STUDY POPULATION
TYPE OF
SNAKE
FEMALE MALE TOTAL
NO. PERCENTAGE NO. PERCENTAGE NO. PERCENTAGEIDENTIFIED
SNAKE NAME
COBRA 10 15.38 20 17.24 30 16.57
KRAIT 11 16.92 12 10.34 23 12.71
RUSELL VIPER 3 4.62 15 12.93 18 9.94
UNIDENTIFIED 41 63.08 69 59.48 110 60.77
TOTAL 65 100.00 116 100 181 100.00
χ² 0.224259182301467
As per table 7.815
Degree of freedom 3
P<0.05
So, the hypothesis is accepted
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FIGURE 20 :- IDENTIFIED SNAKE vs UNIDENTIFIED SNAKE WISE
DISTRIBUTION OF STUDY POPULATION
Out of 181 cases 110 cases did not identify the snake . Of remaining 71 cases
16.57 percent of identified snake was cobra , followed by krait (12.71%) and
rusell viper (9.94%)
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TABLE NO. 4 :- COMORBIDS DISTRIBUTION OF STUDY POPULATION
COMORBIDS
MALE FEMALE TOTAL
No. PERCENTAGE No., PERCENTAGE No., PERCENTAGE
DM 8 6.90 7 10.77 15 8.29
HT 11 9.48 6 9.23 17 9.39
CAHD 2 1.72 3 4.62 5 2.76
CVA 2 1.72 0 0.00 2 1.10
BA/COPD 6 5.17 1 1.54 7 3.87
MALIGNANCY 0 0.00 1 1.54 1 0.55
Residual polio 1 0.86 0 0.00 1 0.55
NIL 80 68.97 46 70.77 126 69.61
CKD 0 0.00 0 0.00 0 0.00
PREGNANT 0 0.00 1 1.54 1 0.55
DM + HT 4 3.45 0 0.00 4 2.21
DM + HT + CAHD 2 1.72 0 0.00 2 1.10
TOTAL 116 94.82758621 65 98.46153846 181 96.13259669
χ² 1.2562E-188
As per table 19.765
Degree of freedom 11
P<0.05
So, the hypothesis is accepted
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FIGURE 21 :- COMORBIDS DISTRIBUTION OF STUDY
POPULATION
Among study population 55 patients have associated co-morbid illness with
around 9.39 percent of patients are hypertensive , 8.29 percent are diabetic
and one patient had old history of  Breast carcinoma  , 1 patient was an
antenatal mother . 2 patients on treatment for DM,SHT and CAHD .
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TABLE  5 : DISTRIBUTION BASED ON TIME OF BITE
TIME OF BITE NUMBER PERCENT
4.00-7:59 AM 18 9.94
8.00-11:59 AM 18 9.94
12.01-3:59PM 26 14.36
4.00-7:59 PM 53 29.28
8.00 – 11.59 PM 40 22.10
12.00 – 4 AM 26 14.36
TOTAL 181 100
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FIGURE 22 : DISTRIBUTION BASED ON TIME OF BITE
Out of  181 , 53 (29.28%) cases ,the time of bite was evening time
between 4.00 pm to 7.59 pm . Least number of bites(9.94%) are distributed in
morning hours i,e 4 to 7.59 am and 8 to 11.59 am . A significant association
was found between time of bite and study population
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TABLE 6 :SITE OF BITE DISTRIBUTION
SITE OF BITE MALE % FEMALE % TOTAL %
FACE 7 6.03 1 1.54 8 4.42
UPPER LIMB 40 34.48 20 30.77 60 33.15
LOWER LIMB 59 50.86 33 50.77 92 50.83
CHEST 5 4.31 0 0.00 5 2.76
ABDOMEN 4 3.45 10 15.38 14 7.73
BACK 1 0.86 1 1.54 2 1.10
TOTAL 116 100 65 100 181 100
χ² 2.19605E-47
As per table 11.07
Degree of freedom 5
P<0.05
So, the hypothesis is accepted
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FIGURE 23 :SITE OF BITE DISTRIBUTION
Among 181 cases , 92 cases (50.83 %) were bitten in lower limb followed by
60(33.15%) of cases were bitten in upper limb . A significant association was
found between site of bite and study population.
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TABLE 7:PLACE OF BITE DISTRIBUTION
SITE OF BITE MALE PERCENT FEMALE PERCENT TOTAL PERCENT
IN-DOOR
26 22.41 24 36.92308 50 27.62
OUT-DOOR
90 77.59 41 63.07692 131 72.38
TOTAL 116 100 65 100 181 100
χ² 1.73683E-09
As per table 3.841
Degree of freedom 1
P<0.05
So, the hypothesis is accepted
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FIGURE 24 :PLACE OF BITE DISTRIBUTION
About 131(72 %)cases are outdoor (farm,work place, school ground,forest)
and 50(28%) are indoor bite ( home, other buildings ). A significant
association was found between place of bite and study population.
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TABLE 8:DISTRIBUTION OF POPULATION BASED ON TOXICITY
Toxicity Male Female Total
Number % Number % Number Percent
Neurotoxic 42 65.62 22 34.38 64 35.36
Haemotoxic 33 71.74 13 28.26 46 25.42
Neurotoxic+haemotoxic 9 60 6 40 15 8.28
Local toxicity 26 63.41 15 36.59 41 22.65
Neuro+local toxicity 5 71.43 2 28.57 7 3.87
Hemo+local toxicity 1 33.33 2 66.67 3 1.66
Neuro+hemo+local 4 80 1 20 5 2.76
χ² 1.73683E-09
As per table 5.6821
Degree of freedom 6
P<0.05
So, the hypothesis is accepted
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FIGURE 25 :DISTRIBUTION OF POPULATION BASED ON
TOXICITY
Neurotoxicity(35.38) is high among the toxicities observed . Next comes the
pure haemo toxicity (25.42%)  . Local reactions like cellulitis ,edema
comprises 22.65 % .
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TABLE 9: DISTRIBUTION BASED ON ASV REACTION
ASV
REACTION MALE PERCENT FEMALE PERCENT TOTAL PERCENT
MILD 40 34.48 24 36.92 64 35.36
SERVERE 14 12.07 3 4.62 17 9.39
NIL 62 53.45 38 58.46 100 55.25
TOTAL 116 100 65 100 181 100
χ² - 3.385E-13 P<0.05
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FIGURE 26 : DISTRIBUTION BASED ON ASV REACTION
Out of 181 cases 100 patients(55%) showed no reaction to ASV
while in remaining 81 cases , 64  (35%) developed minor reactions in the
form of fever , utricarial rashes and rigors . 17 cases (10%) developed severe
anaphylactic reaction
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TABLE 10 :DURATION OF STAY WISE DISTRIBUIION
Of 181 cases maximum number of cases (59.67%) , number of hospital stay
is less than 5 days . Only 16 cases are discharged with in 1 day after treatment
.
DURATION OF
STAY NUMBER PERCENT
<1 day 16 8.84
1-5days 108 59.67
5-10days 41 22.65
10-15days 14 7.73
>15 days 2 1.11
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FIGURE 27 : DURATION OF STAY WISE DISTRIBUTION
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TABLE 11 DEATH Vs ALIVE
Outcome Number Percent
Death 9 4.97
Alive 172 95.03
Total 181 100
9 out of 181 are dead , 172 patients were alive .
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FIGURE  28 :DEATH VS ALIVE
Out of 181 patients 9 patients (4.97)were dead .172 patients (95.03) were
alive .
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χ² 3.66762E-33
As per table 7.815
Degree of freedom 3
P<0.05
So, the hypothesis is
accepted
TABLE 12 :DISTRIBUTION BASED ON NATIVE TREATMENT VS ALIVE
NATIVE
TREATMENT
FEMALE MALE TOTAL
NO % NO % NO %
TOURNIQUETT 20 32.26 28.00 25.45 48 27.91
NIL NATIVE
TREATMENT 41 66.13 76.00 69.09 117 68.02
OTHER 1.00 1.61 6.00 5.45 7.00 4.07
TOTAL 62.00 100.00 110.00 100.00 172.00 100.00
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FIGURE 29 :DISTRIBUTION BASED ON NATIVE TREATMENT VS ALIVE
In patients those who were alive ,history of tourniquet application was
present in 48 (27.91%) cases, 7 cases (4.07%) had history of other methods
of native treatment like cutting ,suction,etc. About 117 cases didnt recieve
any native treatments .
A significant association was found between tourniquet application ,other
native treatments  and study population
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TABLE 13: NATIVE TREATMENT vs MORTALITY WISE
DISTRIBUTION OF STUDY POPULATION
NATIVE
TREATMENT
FEMALE MALE TOTAL
NO % NO % NO %
TOURNIQUET 3.00 100.00 6.00 100.00 9.00 100.00
NIL NATIVE
TREATMENT 0.00 0.00 0.00 0.00 0.00 0.00
OTHER 0.00 0.00 0.00 0.00 0.00 0.00
TOTAL 3.00 100.00 6.00 100.00 9.00 100.00
Out of 9 patients who were dead ,history of  native treatment in the form
tourniquet application , wound cutting, suction etc were present in all cases
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χ² 0.415880232
As per table 11.07
Degree of freedom 5
P<0.05
So, the hypothesis is
accepted
TABLE NO. 14:- BITE TO NEEDLE TIME VS MORTALITY WISE
DISTRIBUTION OF STUDY POPULATION
BITE TO
NEEDLE TIME
MALE FEMALE TOTAL
NO. OF
CASES %
NO. OF
CASES %
NO.
OF
CASES %
< 2 HRS 0 0.00 0 0.00 0 0.00
2.00 -4 HRS 1 16.67 0 0.00 1 11.11
4.00 - 6.00 HRS 1 16.67 0 0.00 1 11.11
6.00 - 8.00 HRS 2 33.33 1 33.33 3 33.33
8.00 - 12.00 HRS 2 33.33 1 33.33 3 33.33
>12.00  HRS 0 0.00 1 33.33 1 11.11
TOTAL 6 100.00 3 100.00 9 100.00
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FIGURE30: BITE TO NEEDLE TIME Vs MORTALITY WISE
DISTRIBUTION OF STUDY POPULATION
Among 9 dead patients , 7 patients(78%) presented late with bite to needle
time of > 6 hours and 2(22%) patients presented less than 6 hours from time
of bite .
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TABLE 15:BITE TO NEEDLE TIME Vs NIL MORTALITY WISE
DISTRIBUTION OF STUDY POPULATION
BITE TO NEEDLE
TIME
MALE FEMALE TOTAL
NO. OF
CASES %
NO. OF
CASES %
NO. OF
CASES %
< 2 HRS 18 10.47 6 200.00 24 13.95
2.00 -4 HRS 47 27.32 25 833.33 72 41.86
4.00 - 6.00 HRS 39 22.67 24 13.96 63 36.63
6.00 - 8.00 HRS 6 3.49 6 3.49 12 6.98
8.00 - 12.00
HRS 0 0.00 1 0.58 1 0.58
>12.00  HRS 0 0.00 0 0.00 0 0.00
TOTAL 110 63.95 62 36.05 172 100
χ² - 2.21983E-35 P<0.05
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`FIGURE 31 :BITE TO NEEDLE TIME Vs NIL MORTALITY WISE
DISTRIBUTION OF STUDY POPULATION
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TABLE 16 :DISTRIBUTION OF PATIENTS BASED ON SURGICAL
PROCEDURES
SURGICAL
PROCEDURES FEMALE PERCENT MALE PERCENT TOTAL PERCENT
FASCIOTOMY 2 1.104 7 3.867 9 4.97
WOUND
DEBRIDEMENT 17 9.392 28 15.47 45 24.86
AMPUTATION 0 0.00 3 1.657 3 1.66
NIL 46 25.41 78 43.-094 124 68.51
TOTAL 65 100 116 100 181 100
χ² - 1.20738E-40 P<0.05
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FIGURE 32 :DISTRIBUTION OF PATIENTS BASED ON SURGICAL
PROCEDURES
Of 181 patients 57 patients had undergone surgical procedures out of which
45 patients (24.8%) had simple wound debridement , 9 cases (4.97%) had
fasiotomy and 3 patients (1.66%) had amputations . Remaining 124 cases
(68.51%) got treated with out any surgical interventions .
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TABLE 17(a) :SURGICAL Vs NON-SURGICAL OUT COME BASED
ON BITE TO NEEDLE TIME
BITTE TO
NEEDLE TIME
FEMALE MALE
SURGICAL
PROC
NON-
SURGICAL
SURGICAL
PROC
NON-
SURGICAL
< 2 HRS 2 5 8 10
2.00 -4 HRS 8 18 17 32
4.00 - 6.00 HRS 6 19 8 27
6.00 - 8.00 HRS 3 3 2 12
8.00 - 12.00 HRS 0 1 0 0
>12.00  HRS 0 0 0 0
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TABLE 17(b) :SURGICAL VS NON-SURGICAL OUT COME BASED
ON BITE TO NEEDLE TIME
BITTE TO NEEDLE
TIME
SURGICAL PROC NON-SURGICAL TOTAL
NO. % NO. %
< 2 HRS 10 40.00 15 60.00 25
2.00 -4 HRS 25 33.33 50 66.67 75
4.00 - 6.00 HRS 14 23.33 46 76.67 60
6.00 - 8.00 HRS 5 25.00 15 75.00 20
8.00 - 12.00 HRS 1 100.00 0 0.00 1
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FIGURE 33:SURGICAL VS NON-SURGICAL OUT COME BASED
ON BITE TO NEEDLE TIME
Out of 25 patients with BTN time < 2 hrs ,40 % had surgery and 60% without
sugery. At BTN time of 2-4 hrs 33% with surgery and 67% without
surgery.At 4-6 hrs values where 23%  with surgery and 77% with out surgery.
At bite to needle time >8 hrs 1 patient underwent surgery.
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TABLE 18 :DISTRIBUTION OF STUDY POPULATION BASED ON  TIME OF BITE VS SITE OF BITE
SITE OF
BITE
4.00-7:59
AM
8.00-11:59
AM
12.01-
3:59PM
4.00-7:59
PM
8.00 – 11.59
PM 12.00 – 4.00 AM TOTAL
NO. % NO. % NO. % NO. % NO. % NO. % NO. %
FACE 0 0.00 4 30.77 4 30.77 3 23.08 2 15.38 0 0.00 13 100.00
UPPER
LIMB 6 13.33 3 6.67 14 31.11 6 13.33 5 11.11 11 24.44 45 100.00
LOWER
LIMB 6 9.52 10 15.87 7 11.11 20 31.75 15 23.81 5 7.94 63 100.00
CHEST 2 7.41 7 25.93 17 62.96 1 3.70 0 0.00 0 0.00 27 100.00
ABDOMEN 0 0.00 3 14.29 6 28.57 1 4.76 10 47.62 1 4.76 21 100.00
BACK 0 0.00 6 50.00 5 41.67 0 0.00 1 8.33 0 0.00 12 100.00
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FIGURE 34: DISTRIBUTION OF STUDY POPULATION BASED ON  TIME OF BITE VS SITE OF BITE
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TABLE 19 COMORBID VERSUS  DEATH WISE  DISTRIBIUTION
CO MORBID
ILLNESS
NUMBER DEAD ALIVE
NUMBER % NUMBER %
DM 15
1 6.67 14 93.33
HT 17
1 5.88 16 94.12
CAHD 5
0 0 5 100
CVA 2
0 0 2 100
BA/COPD 7
0 0 7 100
MALIGNANCY 1
0 0 1 100
Residual polio 1
0 0 1 100
PREGNANT 1
0 0 1 100
DM + HT 4
1 25 3 75
DM + HT +
CAHD 2
0 0 2 100
NIL 126
6 4.76 120 95.24
Total 181
9 4.97 172 95.03
χ² 1.20738E-40
As per table 7.815
Degree of freedom 10
P<0.05
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FIGURE 35:COMORBID VERSUS  DEATH WISE  DISTRIBIUTION
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DISCUSSION
AGE:
Among 181 cases, most of the victims (26.8%) belongs to fourth decade
of life. Many similar studies conducted in the past show similar distribution
.One such study in JIPMER
60
show  that majority of victims belong to 15-60
yrs of age. Another study by Sawai et al show that most of the cases belong to
10 to 30 years . There is arapid decline in the incidence of  cases after 5th
decade of life .
SEX :
In our study Male to female ratio of incidence of bite is 1.8:1 . Comparing
this with studies done earlier like study conducted by Banerjee RN61 ,a higher
preponderance of males than females was observed .
OCCUPATION:
Similar to studies done at JIPMER
60
and in Safturjang hospital 61 our
present study clearly showed that the incidence of bite is more among
96
agricultural workers i,e 46.41% in our present study .We also observed that
10 victims (5.52%) are school or college students .
IDENTIFICATION OF SNAKE:
In our present study we noticed majority of patients (60.77%) did not
identify the snake . Among the identified cases , most common was cobra
(16.57%) followed by krait (12.71%)
CO MORBID CONDITIONS:
To evaluate the outcome of patients in relation to co morbid illness , We
obtained a deiailed history of co morbid illness among snake bite victims
.Nearly 9.39 % of cases were hypertensives and 8.29% were diabetic . One
patient was antenatal mother (5 months gestation).
TIME OF BITE :
In our present study ,maximum incidence of snake bite(29.28%) was
between 4:00 PM to 8:00 PM . Least number of bites were  distributed in
morning hours i,e 4 to 8:00am(9.94%)  and 8 to 11.59 am(9.94%).
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SITE OF BITE:
Among 181 cases 50.83% of victims repoted to have bitten in lower limb
and most common site was feet.other sites in decreasing order were upper
limb (33.15%),abdomen (7.73%) and face (4.42%) .These findings clearly
suggests that the site of bite is determined mainly by inadvertent contact of
the snake during activities .All these findings are more or less similar to that
of study conducted by Virumani SK
62
dutt  OP and Bhat RN
PLACE OF BITE:
About 131(72 %)cases are outdoor (farm,work place, school
ground,forest),
and 50(28%) cases  are indoor bite ( home, other buildings ).
TOXICITY:
Neurotoxicity(35.38) is high among the toxicities observed . Next comes
the pure haemo toxicity (25.42%)  . Local reactions like cellulitis ,edema
comprises 22.65 % .
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BITE TO NEEDLE TIME:
Bite to needle time is the interval between time of bite and administration
of ASV .42% cases were given ASV with in 2-4 hrs of bite , followed by 36%
of cases with in 4-6 hrs . This helps in the evaluation of severity and
administration of ASV in a crucial period
NATIVE TREATMENT:
In patients those who were alive ,history of tourniquet application was
present in 48 (27.91%) cases, 7 cases (4.07%) had history of other methods of
native treatment like cutting ,suction,etc. About 117 cases didnt recieve any
native treatments . A significant association was found between tourniquet
application ,other native treatments  and study population. Out of 9 patients
who were dead ,history of  native treatment in the form tourniquet
application, wound cutting, suction etc were present in all cases.
ASV REACTIONS:
Out of 181 cases 100 patients(55%) showed no reaction to ASV while
in remaining 81 cases , 64  (35%) developed minor reactions in the form of
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fever , urticarial rashes and rigors . 17 cases (10%) developed severe
anaphylactic reactions. This clearly shows that majority of cases who
received ASV developed no or only mild reaction to ASV .
BITE TO NEEDLE TIME AS A FACTOR FOR DETERMINING
MORTALITY:
Among 9 dead patients , 7 patients(78%) presented late with bite to
needle time of > 6 hours and 2(22%) patients presented less than 6 hours from
time of bite.
SURGICAL PROCEDURES :
Of 181 patients 57 patients had undergone surgical procedures out of
which 45 patients (24.8%) had simple wound debridement , 9 cases (4.97%)
had fasciotomy and 3 patients (1.66%) had amputations . Remaining 124
cases (68.51%) got treated with out any surgical interventions .
COMORBID VERSUS  DEATH WISE  DISTRIBIUTION :
On analysing co morbid illness versus death wise distribution of
study population , we found that among 15 diabetic patients 93.33 % were
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alive and 6.67% were dead . Among  17 hypertensive patients only 5.88%
died . Similarly on analysing all the co morbid datas we found that co morbid
illness is less significant in determining the mortality .
ANTENATAL CASE OF SNAKE BITE:
We had one ante natal women (5 months of gestation ) who
received ASV in 4 hours and she was alive .But resulted  in intra uterine
death due to foeticidal effect of ASV . On analysing various ante natal snake
bite cases in the past the foeticidal effect of ASV is confirmed .
SURGICAL VS NON-SURGICAL OUT COME BASED ON BITE TO
NEEDLE (BTN)TIME :
On analysis of bite to needle time with surgery . we found that
out of 25 patients with BTN time < 2 hrs ,40 % had surgery and 60% without
surgery.
At BTN time of 2-4 hrs 33% with surgery and 67% without surgery. At 4-6
hrs values where 23%  with surgery and 77% without surgery . At >8 hrs 1
patient with surgery . This shows that unlike  bite to needle time as an
important determinant of mortality , it’s not an important determinant in case
of surgical interventions.
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CONCLUSION
Snakebite although  a  preventable problem , it remains to be one of
the common emergency.
1)  In the present study, the adult snakebite cases with envenomation
brought to Government Chengalpattu Medical College & Hospital,
Chengalpattu,  were mostly  males(64%)between the age group of 30 to 40
years(26.8%)
2)With rural background, snake bite is more common among
agricultural related activities (46.41%)
3)The most common site of bite was lower limb and the maximum
cases were recorded between 4:00 PM to 8:00 pm (29.28%)in the rainy
season of July to September.
4) Neurotoxicity constitutes (35.38%) among all the toxicities
followed by  pure haemo toxicity (25.42%) and local reactions like cellulitis
edema ( 22.65 %).
5)      A significant association was noted between prolonged bite to
needle time and mortality with  7  out of 9 patients(78%) who presented more
than 6 hours after bite  were dead .
6) On analysing co morbid illness versus death wise distribution of
study population , we found that among 15 diabetic patients 93.33 % were
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alive and 6.67% were dead . Among  17 hypertensive patients only 5.88%
died . Similarly on analysing all the co morbid illness with outcome we found
that co morbid illness is not a strong determinant in determining the mortality.
7)Native treatment  especially tourniquett application is a strong
determinant of outcome with 100% prevalence in dead and 85.28%  in
patients who had undergone  surgeries and 27.28 % in alive patients with out
surgeries .
SUGGESTIONS FOR PREVENTING MORTALITY :
Mortality due to snakebite poisoning can be reduced by taking certain steps:
1) Administer first aid as early as possible  in  case of snakebite poisoning
2) Always take the patients to the nearest health care facility for proper
medical treatment
3) If the snake was identified ,should inform it without fail to the doctor
to initiate early treatment based on expected toxicity.
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4) Whole blood clotting time should be done in all the cases and ASV
should be administered when it is prolonged.
5) Avoid native treatments like tourniquet applications, wound puncturing
and suction. The bitten site should be immobilised and patient should
be taken to nearest hospital
6) Always administer recommended dose of antisnake venom as soon as
the patient is brought to the hospital , and do not wait for any pending
investigations .
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LIMITATIONS OF STUDY
1. Mortality is very low( 9 out of 181 cases ) to analyse the risk factor
association
2. Smaller sample size
3. Chances of confounding bias are more
4. Absconded cases are excluded from study .
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PROFORMA
1.NAME /NO :
2.AGE :
3.SEX:
4.OCCUPATION:
5.COMORBIDS:
6.TIME OF BITE:
7.NO OF WARDS / IMCU
STAY:
8.SITE OF BITE:
9.PLACE OF BITE :
10.SNAKE IDENTIFIED :
11.TORNIQUET APPLICATION
12.SIGNS OF TOXICITY :
13.BITE TO NEEDLE TIME :
14.ASV DOSE AS PER
NATIONAL PROTOCOL:
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15.REACTIONS TO ASV :
16.BLEEDING TIME :
17.CLOTTING TIME:
18.RFT :
19.PLATELET COUNT:
20.CHEST X RAY:
21.ECG:
22.URINE R/E:
23.OTHERS:
24. HOSPITAL STAY > 5 DAYS
25.SURGERIES :
26.PERMANENT
DISABILITIES :
27.MORTALITY :
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KEY TO MASTER CHART
CODING
Q1. ENROLLED NUMBER OF THE PATIENT :
Q2.AGE :    1. 13 -18 YRS (MINOR)            6.42-47                  11.72-77
2.19-24 YRS                               7.48-53
3.25-30 YRS                               8.54-59
4.31-35 YRS                               9.60-65
5.36-41 YRS 10.66-71
Q3.SEX : 1.MALE         2.FEMALE
Q4.OCCUPATION :  1. AGRICULTURE 2.INDUSTRY 3.STATE GOVT
(SWEEPER, SANITARY WORKER ,ETC )     4.CENTRAL GOVT
5.BUSINESS 6.SMALL TRADE 7.PRIVATE 8.NOT WORKING /HOME
MAKE 9)FOREST WORKER 10)STUDENT  11)SNAKE HANDLER
Q5.CO MORBIDS : 1.DM 2.HT 3.CAHD 4.CVA 5.BA/COPD  6.
MALIGNANCY 7. NEUROLOGICAL DEFICIT   8.NIL  9.CKD
10.PREGNANT
Q6.TIME OF BITE :1. 4-7:59 AM
2. 8-11:59 AM
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3. 12-3:59PM
4. 4-7:59 PM
5. 8 – 11.59 PM
6.12 – 4 AM
Q7.NO OF WARD/IMCU STAY : 1.<24 HRS   2. 24 HRS TO 5 DAYS     3.
5-10 DAYS 4.10-15 DAYS 5.15-30 DAYS  6.> 1 MONTH
Q8.PLACE OF BITE : 1. FACE  2. UPPER LIMB 3. LOWER LIMB   4.
CHEST  5. ABDOMEN  6. BACK
Q9. SITE OF BITE :  1. INDOOR 2. OUTDOOR
Q10.SNAKE IDENTIFIED : 1.COBRA  2. KRAIT 3.RUSELL VIPER
4.SAW SCALE VIPER 5. OTHER 6. NOT IDENTIFIED
Q.11.NATIVE TREATMENT : 1. TOURNIQUET 2.NO TOURNIQUET
3.CUTTING/PUNCTURING/BITING/NICKING
Q12.SIGNS OF TOXICITY : 1. NEUROTOXICITY   2.
HAEMOTOXICITY  3.BOTH  4. LOCAL EDEMA /         CELLULITIS
5.OTHERS
Q13.BITE TO NEEDLE TIME : 1. < 2 HRS/ 2.2-4 HRS/ 3. 4-6 HRS/ 4.6-8
HRS /5. 8-12 HRS/ 6. > 12 HRS
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Q14.ASV DOSE AS PER NATIONAL PROTOCOL :  1. NEUROTOXIC
(10+10)  2.HAEMOTOXIC  3.10 VIALS 4.8   VIALS
Q15.. REACTIONS TO ASV : 1. MILD  2.SEVERE 3.NIL
Q16.    CLOTTING TIME : 1.NORMAL   2.PROLONGED
Q17.    RFT: 1.NORMAL   2.ABNORMAL
Q18   PLATELET COUNT 1. NORMAL   2.ABNORMAL
Q19   CHEST XRAY   : 1 .NORMAL    2. ABNORMAL
Q20 ECG : 1 .NORMAL    2. ABNORMAL
Q21.URINE R/E  : 1 .NORMAL    2. ABNORMAL
Q22. STAY > 5 DAYS : 1 . YES             2. NO
Q23..SURGICAL PROCIDURES  : 1. AMPUTATION  2.FASCIOTOMY
3.WOUND DEBRIDEMENT 4.NIL
Q24MORTALITY : 1 .YES    2. NO
Q25. VENTILATOR : 1.YES 2.NO
Q26.OTHER TREATMENTS : 1. FFP 2.DIALYSIS 3.NIL
119
q1
 no
q2
 ag
q3
 se
x
q4
 oc
c
q5
 m
orb
q6
tim
e
q7
 st
ay
q8
 pl
ace
q9
 sit
e
q1
0 i
d
q1
1 n
.tr
e
q1
2to
xi
q1
3 b
 to
 n
q1
4 d
ose
q1
5 r
ea
ct
q1
6 C
.T
q1
7  
RF
T
q1
8  
PLT
q1
9 C
XR
q2
0  
EC
G
q2
1U
R/E
q2
2 s
ta>
5
q2
3su
rg
q2
4 p
.di
s
q2
5 m
ort
q2
6 v
en
ti
q2
7 o
the
1 6 2 8 5 3 2 3 2 6 2 2 2 2 1 2 1 1 1 1 1 2 3 5 2 2 3
2 2 1 1 8 6 3 5 2 6 2 3 2 1 3 2 1 1 1 1 1 1 3 5 2 2 3
3 6 1 1 8 2 3 3 2 1 1
3,
4 3 1 3 2 1 1 1 1 1 1 1 5 2 2 3
4 7 2 1 8 6 2 2 2 3 1 2 1 2 2 2 1 1 1 1 1 1 3 5 2 2 3
5 5 2 1 8 1 2 2 2 6 1 2 2 2 3 2 1 1 1 1 1 1 3 5 2 2 3
6 8 1 1 8 1 2 2 2 6 2 2 1 2 3 2 1 1 1 1 1 1 3 5 2 2 3
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11 1 1 10 8 1 3 2 2 6 1 1 2 1 3 1 1 1 1 1 1 1 3 5 2 1 3
12 7 1 1 3 4 2 3 2 6 2 2 2 2 3 2 1 1 1 1 1 2 3 5 2 2 3
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17 1 1 8 8 6 2 2 1 1 2 1 3 1 3 1 1 1 1 1 1 2 2 5 2 1 3
18 7 1 1 8 1 2 2 2 1 2 4 2 1 1 1 1 1 1 1 1 2 2 5 2 2 3
19 2 1 3 8 1 1 2 1 2 2 1 1 1 1 1 1 1 1 1 1 2 2 5 2 2 3
20 4 1 1 8 3 1 2 2 6 2 2 1 2 3 2 1 1 1 1 1 2 2 5 2 2 3
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118 5 1 1 8 2 3 3 2 2 2 1 3 1 3 1 1 1 1 1 1 1 3 5 2 1 3
119 1 2 10 8 1 3 2 1 6 2 1 2 1 3 1 1 1 1 1 1 1 3 5 2 1 3
120 6 1 1 8 4 2 3 2 3 1 4 2 3 3 1 1 1 1 1 1 2 3 5 2 2 3
121 2 1 1 8 3 4 2 2 6 2 1 2 1 2 1 1 1 1 1 1 2 3 5 2 2 3
122 9 2 8 8 6 2 3 2 6 2 2 3 2 1 2 1 1 1 1 1 2 3 5 2 2 3
123 5 1 3 2 4 3 5 1 2 2 4 3 1 3 1 2 1 1 1 1 1 3 5 2 1 3
124
124 8 1 1 8 2 4 1 2 6 1 1 2 2 3 1 1 1 1 1 1 1 3 5 2 2 3
125 6 2 1 1 6 2 3 1 6 2 2 2 1 1 1 1 1 1 1 1 2 3 5 2 2 3
126
1
0 1 1 8 4 1 3 2 4 2 4 3 2 1 2 1 1 1 1 1 2 3 5 2 2 3
127 4 1 1 8 3 2 2 3 3 1 2 3 2 2 2 1 1 1 1 1 2 3 5 2 2 3
128 6 2 7 8 4 2 3 2 6 1 4 3 2 3 1 1 1 1 1 1 2 2 5 2 2 3
129 4 1 1 8 3 2 2 3 3 1 2 3 2 2 2 1 1 1 1 1 2 3 5 2 2 3
130 5 2 8 8 5 4 5 1 6 2 1 3 1 1 1 1 1 1 1 1 1 3 5 2 1 3
131 4 1 1 8 3 1 2 2 6 2 2 1 2 3 2 1 1 1 1 1 2 3 5 2 2 3
132 3 1 7 8 3 2 2 2 6 2 1 2 1 1 1 1 1 1 1 1 2 3 5 2 2 3
133 5 1 1 8 4 1 2 2 6 2 2 1 2 3 2 1 1 1 1 1 2 3 5 2 2 3
134 4 1 1 8 3 2 2 3 3 1 2 3 2 2 2 1 1 1 1 1 2 3 5 2 2 3
135
1
0 1 1 1 2 4 3 2 1 1 3 2 1 3 2 2 2 1 1 2 1 2 3 2 2 2
136 4 2 8 1 4 2 2 1 2 1 2 2 1 1 1 1 1 1 1 1 2 2 5 2 2 3
137 8 1 1 8 3 3 4 1 6 2 1 3 1 1 1 1 1 1 1 1 1 3 5 2 1 3
138 6 2 8 8 5 4 5 1 6 2 1 3 1 1 1 1 1 1 1 1 1 3 5 2 1 3
139 9 1 1 8 6 3 2 2 6 2 4 3 1 3 1 1 1 1 1 1 1 1 5 2 2 3
140 9 1 1 8 5 2 3 2 6 2 4 2 3 3 1 1 1 1 1 1 2 2 5 2 2 3
141 2 1 10 8 8 3 2 3 6 2 2 1 1 1 1 1 1 1 1 1 1 2 5 2 2 3
142 6 2 8 8 5 4 5 1 6 2 1 3 1 1 1 1 1 1 1 1 1 3 5 2 1 3
143 8 1 3 2 4 3 2 1 2 2 1 3 1 3 1 2 1 1 1 1 1 3 5 2 1 3
144 6 2 8 8 5 4 3 1 6 2 1 3 1 1 1 1 1 1 1 1 1 2 5 2 1 3
145
1
1 1 1 5 5 2 2 1 2 2 1 1 1 1 1 1 1 1 1 1 2 2 2 2 1 3
146 8 1 1 8 5 2 3 2 6 2 4 2 3 3 1 1 1 1 1 1 2 3 5 2 2 3
147 4 1 9 1,2 4 2 3 2 6 1 2 2 1 3 2 2 1 1 1 1 2 2 5 2 2 3
148 6 1 1 1 6 2 3 1 6 2 2 2 1 1 1 1 1 1 1 1 2 3 5 2 2 3
125
149 6 2 7 8 4 2 3 2 6 1 4 3 3 3 1 1 1 1 1 1 2 2 2 2 2 3
150 4 1 6 8 2 3 3 1 3 1 3 1 1 1 2 2 1 1 1 1 1 3 3 2 2 2
151 3 1 1 8 1 2 3 2 6 2 2 3 2 3 2 1 1 1 1 1 2 3 5 2 2 3
152 5 2 8 8 4 4 3 2 6 1
1,
2,
4 3 1 1 2 2 1 1 1 1 1 3 4 1 1 1
153 9 2 8 1 4 2 2 1 2 1 1 2 1 1 1 1 1 1 1 1 2 2 2 2 2 3
154 7 1 1 8 3 3 4 1 6 2 1 3 1 1 1 1 1 1 1 1 1 3 5 2 1 3
155 9 1 8 8 2 2 3 2 6 2 4 4 2 3 1 1 1 1 1 1 1 3 5 2 2 3
156 5 2 8 8 5 4 5 1 6 2 1 3 1 1 1 1 1 1 1 1 1 3 5 2 1 3
157 7 2 1 1 4 2 3 2 1 2 1 4 1 3 1 1 1 1 1 1 2 3 5 2 2 3
158 6 1 1 8 5 3 1 1 6 2 1 2 1 3 1 1 1 1 1 1 1 3 5 2 1 3
159 4 1 1 5 6 3 2 2 6 2 2 2 2 1 2 1 1 1 1 1 1 3 5 2 2 1
160 7 2 1 8 3 2 3 2 6 2 1 3 1 2 1 1 1 1 1 1 2 3 4 2 2 3
161 7 1 11 1,2 4 3 1 2 1 1
1,
4 4 1 3 1 2 1 1 1 1 1 3 5 1 1 3
162 3 1 8 8 6 2 2 1 3 1
1,
4 4 2 3 1 1 1 1 1 1 1 2 5 2 2 3
163 4 2 2 8 4 1 3 2 6 2 4 2 3 3 1 1 1 1 1 1 2 3 5 2 2 3
164 9 1 1
1,2
,3 4 2 3 2 1 1 2 2 1 3 2 1 1 1 2 2 1 3 5 2 1 3
165 3 2 8 8 6 2 3 2 6 2
1,
2 2 1 1 2 1 1 1 1 1 2 3 5 2 2 3
166 5 2 8 8 4 2 3 2 6 1 4 2 2 3 1 1 1 1 1 1 2 3 5 2 2 3
167 9 1 8 1 4 3 2 2 6 2 1 4 1 1 1 1 1 1 1 1 1 3 1 2 3
168 6 1 3 2 5 3 3 1 2 2 1 3 1 3 1 2 1 1 1 1 1 3 5 2 1 3
169 4 2 5 8 5 3 5 1 6 2 1 3 1 1 1 1 1 1 1 1 1 3 5 2 1 3
170 9 1 1 8 6 3 3 2 6 2 4 3 1 3 1 1 1 1 1 1 1 1 5 2 2 3
171 7 1 1 8 5 2 3 1 6 2 4 2 3 3 1 1 1 1 1 1 2 2 5 2 2 3
126
172 3 1 1 8 1 2 3 2 6 2 2 3 2 3 2 1 1 1 1 1 2 3 5 2 2
173 6 2 4 2 5 4 5 1 6 2 1 3 1 1 1 1 1 1 1 1 1 3 5 2 1 3
174 7 1 1 8 4 3 4 1 1 2 1 3 1 1 1 1 1 1 1 1 1 3 5 2 1 3
175 4 1 1 8 3 2 2 3 3 1 2 3 2 2 2 1 1 1 1 1 2 3 5 2 2 3
176 3 1 1 2 4 2 3 2 6 2 1 2 1 1 1 1 1 1 1 1 2 2 5 2 2 3
177 2 1 10 8 4 2 3 2 6 2 4 2 3 1 1 1 1 1 1 1 2 2 5 2 2 3
178 5 1 5 1 6 3 3 2 1 2 4 3 2 1 1 1 1 1 1 1 1 1 1 2 2 3
179 7 1 8 2 4 3 2 2 1 1
1,
4 3 1 3 1 1 1 1 1 1 1 2 5 2 2 3
180 8 1 1 8 5 2 3 2 6 2 4 2 3 3 1 1 1 1 1 1 2 2 5 2 2 3
181 4 1 3 2 4 3 2 1 2 2 1 3 1 3 1 2 1 1 1 1 1 3 5 2 1 3
